United States Begins Coronavirus Vaccine Roll Out, Gives Approval To Pfizer and Moderns

United States Begins Coronavirus Vaccine Roll Out, Gives Approval To Pfizer and Moderns

The Food and Drug Administration (FDA), the agency responsible for the authorization and sale of drugs in the United States, this Thursday evaluated Moderna's vaccine as a step towards its approval, as first-week Pfizer vaccines are already being administered.

Biotech's product will be included in the largest vaccination campaign to be carried out in the United States in conjunction with Pfizer / Bioentech, which began on Monday.

"Every day in the United States, a significant step is taken in the fight against the epidemic that causes so many hospitals and deaths," the FDA said.

Today, FDA issued an emergency use authorization (EUA) for the second vaccine for the prevention of #COVID19 caused by SARS-CoV-2. The emergency use authorization allows the vaccine to be distributed in the U.S for use in individuals 18 years and older. https://t.co/w4BQVg0n2G pic.twitter.com/cw5JwYqxsh

— U.S. FDA (@US_FDA) December 19, 2020

Urgent approval of the vaccine brings Govit-19 the second vaccine to prevent the U.S. population within a week, and millions of doses are expected to begin being distributed immediately to health workers and long-term care residents.

Moderna's vaccine is 94% effective in preventing Covit-19, and is approved for adults 18 and older. Recognition comes after being recommended by an FDA advisory panel of independent experts.

Pfizer's vaccine uses the same technology as the first to prevent Covid-19, which was approved in the United States last week. Both companies are expected to apply for full approval of the vaccine in the coming months. Federal officials believe 20 million people will be vaccinated by the end of this year.

The vaccine, developed by Pfizer, is being approved by the FDA last week as it is being offered to health workers and long-term care residents.

Video In Tamil